Using ALK+ lung cancer patient-derived cell lines, researchers have performed phosphoproteomic screening and identified guanylate kinase 1 (GUK1) as a TKI sensitive metabolic molecule in ALK-driven ...
An expert explained the importance of the FDA’s approval of Ensacove for patients with ALK-positive non-small cell lung ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback